VEGF is associated with the poor survival of patients with prostate cancer: a meta-analysis

BACKGROUND: Vascular endothelial growth factor (VEGF) is considered as a prime mediator of angiogenesis, and has been implicated in carcinogenesis and metastasis. Various studies examined the relationship between VEGF overexpression with the clinical outcome in patients with prostate cancer, but yie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Ping, Ji, Ya-Nan, Yu, Li-Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708223/
https://www.ncbi.nlm.nih.gov/pubmed/26816732
http://dx.doi.org/10.3978/j.issn.2223-4683.2013.06.03

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708223/
https://www.ncbi.nlm.nih.gov/pubmed/26816732
http://dx.doi.org/10.3978/j.issn.2223-4683.2013.06.03

Ejemplares similares